west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "范成中" 5 results
  • 131I 治疗甲状腺功能亢进症伴2型糖尿病的护理

    目的 总结甲状腺功能亢进症(甲亢)合并2 型糖尿病患者的护理方法。 方法 对2008年3月-2011年10月期间核医学科收治的20例经131I治疗的甲亢伴2型糖尿病患者的临床治疗中的护理进行回顾性分析。 结果 通过131I治疗与核医学科专科护理,20例患者中有18例甲状腺功能恢复至正常水平或得到改善,12例空腹血糖水平控制在(6.0 ± 1.2)mmol/L,餐后2 h 血糖水平控制在(7.9 ± 1.7)mmol/L。 结论 核医学科专科护理有助于131I治疗甲亢合并2 型糖尿病患者的病情控制,减少并发症的发生。

    Release date: Export PDF Favorites Scan
  • A review on cardiac positron emission tomography/magnetic resonance imaging in diagnosis of cardivascular diseases

    There are various examination methods for cardiovascular diseases. Non-invasive diagnosis and prognostic information acquisition are the current research hotspots of related imaging examinations. Positron emission tomography (PET)/magnetic resonance imaging (MRI) is a new advanced fusion imaging technology that combines the molecular imaging of PET with the soft tissue contrast function of MRI to achieve their complementary advantages. This article briefly introduces several major aspects of cardiac PET/MRI in the diagnosis of cardiovascular disease, including atherosclerosis, ischemic cardiomyopathy, nodular heart disease, and myocardial amyloidosis, in order to promote cardiac PET/MRI to be more widely used in precision medicine in this field.

    Release date:2020-12-14 05:08 Export PDF Favorites Scan
  • 18F-Berberine Derivatives: a Potential Molecular Imaging Agent for Tumor Targeting by PET/CT Tumor

    Cancer is one of the main causes of death for human beings. Clinical oncologists increasingly rely upon imaging for diagnosis, stage, response assessment, and follow-up in cancer patient. However, 18F-FDG is not a tumor specific agent, inflammation and infection also have intensive uptake of 18F-FDG, resulting in false positive diagnosis, and some tumors have low uptake of 18F-FDG or even do not uptake 18F-FDG, leading to false negative diagnosis. So it is urgent to develop non-18F-FDG novel tumor targeting agent. Recently, a large number of researches in vitro have demonstrated that berberine has anti-tumor activity against a variety of tumor cells by inducing tumor cell apoptosis through inhibition of mitochondrial respiratory chain etc. So far, there is no credible evidence of berberine targeting in tumor in vivo. We proposed a hypothesis that berberine has the characteristics of tumor targeting biodistribution in vivo, and verified the proposal by 18F-berberine PET/CT imaging in VX2 muscle tumor-bearing rabbit model. In this review, we intend to give an overview of the progress of berberine anticancer, the structural bases of berberine anticancer and the uderlying molecular mechanisms of berberine anticancer indentified so far. We also introduce the first visualization of 18F labeled berberine derivatives targeting tumor in VX2 muscle tumor-bearing rabbit model by PET/CT. These breakthrough findings suggest that 18F-berberine derivatives as a potential PET/CT tumor targeted molecular imaging agent may have important implications for cancer targeting therapy, molecular imaging and modernization of Traditional Chinese Medicine.

    Release date: Export PDF Favorites Scan
  • 黄连素衍生物(氟[19F]HX-01)体外靶向肝癌的初步研究

    [18F]HX-01, a Fluorine-18 labeled berberine derivative, is a potential positron emission tomography (PET) tumor imaging agent, while [19F]HX-01 is a nonradioactive reference substance with different energy state and has the same physical and chemical properties. In order to collect data for further study of [18F]HX-01 PET imaging of hepatocellular carcinomain vivo, this study compared the uptake of [19F]HX-01 by human hepatocellular carcinoma and normal hepatocytesin vitro. The target compound, [19F]HX-01, was synthesized in one step using berberrubine and 3-fluoropropyl 4-methylbenzenesulfonate. Cellular uptake and localization of [19F]HX-01 were performed by a fluorescence microscope in human hepatocellular carcinoma HepG2, SMMC-7721 and human normal hepatocyte HL-7702. Cellular proliferation inhibition and cell cytotoxicity assay of the [19F]HX-01 were conducted using cell counting kit-8 (CCK-8) on HepG2, SMMC-7721 and HL-7702 cells. Fluorescent microscopy showed that the combining ability of [19F]HX-01 to the carcinoma SMMC-7721 and HepG2 was higher than that to the normal HL-7702. Cellular proliferation inhibition assay demonstrated that [19F]HX-01 leaded to a dose-dependent inhibition on SMMC-7721, HepG2, and HL-7702 proliferation. Cell cytotoxicity assay presented that the cytotoxicity of [19F]HX-01 to SMMC-7721 and HepG2 was obviously higher than that to HL-7702. Thisin vitro study showed that [19F]HX-01 had a higher selectivity on human hepatocellular carcinoma cells (SMMC-7721, HepG2) but has less toxicity to normal hepatocytes (HL-7702). This could set up the idea that the radioactive reference substance [18F]HX-01 may be worthy of further development as a potential molecular probe targeting human hepatocellular carcinoma using PET.

    Release date:2017-04-13 10:03 Export PDF Favorites Scan
  • 正电子发射型计算机断层显像/计算机断层显像检查中的护理配合

    目的 探讨在正电子发射型计算机断层显像/计算机断层显像(PET/CT)检查中护理配合的重要性。 方法 对2012年1月-6月905例行PET/CT检查者的护理流程及操作规范进行分析总结,并就检查中的护理要点及配合方法予以逐一阐述。 结果 903例患者顺利完成检查,2例肿瘤骨转移患者因严重疼痛,肌肉注射杜冷丁后仍不能继续配合检查而中途放弃。 结论 患者、护士、医生的通力协作配合,是完成PET/CT检查并获得高质量影像资料的重要保证。

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content